Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -4561.25x as of the fiscal period ended Thursday, December 31, 2020.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2020 (2020-12-31): -4561.25x.
INTEREST COVERAGE RATIO
-4561.25x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
-773.70x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
-489.54%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-71449.05%
vs the sector median at left
Cellectar Biosciences, Inc.
Market Cap
$12.54M
Interest Coverage Ratio
-4561.25x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.51M
Interest Coverage Ratio
-16.47x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.43M
Interest Coverage Ratio
-128.38x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.77M
Interest Coverage Ratio
-5.45x
TTM Avg
0.92x
3Y Avg
0.92x
5Y Avg
0.92x
Market Cap
$12.31M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.29M
Interest Coverage Ratio
-1171.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.12M
Interest Coverage Ratio
N/A
TTM Avg
4.58x
3Y Avg
5.23x
5Y Avg
12.43x
Market Cap
$13.20M
Interest Coverage Ratio
-143.87x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cellectar Biosciences, Inc. (CLRB) | $12.54M | -4561.25x | N/A | N/A | N/A |
| Dare Bioscience, Inc. (DARE)vs › | $12.51M | -16.47x | N/A | N/A | N/A |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.43M | -128.38x | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.77M | -5.45x | 0.92x | 0.92x | 0.92x |
| Lantern Pharma Inc. (LTRN)vs › | $12.31M | N/A | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.29M | -1171.55x | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.12M | N/A | 4.58x | 5.23x | 12.43x |
| Passage Bio, Inc. (PASG)vs › | $13.08M | N/A | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | -143.87x | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.76M | -20.24x | N/A | N/A | N/A |
Interest Coverage
-4561.3x
Debt/Equity
0.05
Current Ratio
6.66
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2020-12-31 | -4561.25x |
| 2015-03-31 | -1306.78x |
| 2014-12-31 | -224.36x |
| 2014-09-30 | -8.98x |
| 2014-06-30 | -22.34x |
| 2014-03-31 | -40.71x |
| 2013-12-31 | -1810.11x |
| 2013-09-30 | -1298.73x |
| 2013-06-30 | -1228.60x |
| 2013-03-31 | -1023.90x |
| 2012-12-31 | -698.96x |
| 2012-09-30 | -979.97x |
| 2012-06-30 | -1066.81x |
| 2012-03-31 | -1122.58x |
| 2011-12-31 | -1005.27x |
| 2011-09-30 | -1300.98x |
| 2011-06-30 | -8.34x |
| 2011-03-31 | -5.47x |
| 2010-09-30 | -6.52x |
| 2010-06-30 | -15.94x |
